Latest Breaking News On - Orchestra biomed holdings - Page 1 : comparemela.com

Chardan Capital Weighs in on Orchestra BioMed Holdings, Inc s FY2024 Earnings (NASDAQ:OBIO)

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO – Free Report) – Equities research analysts at Chardan Capital issued their FY2024 earnings per share (EPS) estimates for Orchestra BioMed in a research report issued to clients and investors on Tuesday, May 14th. Chardan Capital analyst K. Nakae forecasts that the company will post earnings per share of ($1.48) […]

Orchestra biomed holdings incTd asset management incJefferies financial groupOrchestra biomed company profileYork mellon corpAllspring global investments holdingsOrchestra biomed holdingsFree reportChardan capitalOrchestra biomedGet free reportGlobal investments holdingsNew york mellon corpManagement incBiomed holdingsBackbeat cardiac neuromodulation therapy

Orchestra BioMed (OBIO) Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors

Orchestra BioMed (OBIO) Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid hochmanSiemens healthineersDavid pacittiSiemens medical solutions united states incOrchestra biomed holdings incResearch developmentDivision viceOrchestra biomed holdingsSiemens medical solutions united statesDivision vice presidentAbbott vascularSenior executive staffOrchestra biomed boardOrchestra biomed

Orchestra BioMed Holdings, Inc (NASDAQ:OBIO) Short Interest Up 7 6% in January

Orchestra BioMed Holdings, Inc (NASDAQ:OBIO) Short Interest Up 7 6% in January
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United kingdom generalUnited kingdomPerceptive advisorsBlackrock incOrchestra biomed holdings incJefferies financial groupVanguard group incOrchestra biomed company profileCharles schwab investment management incGeode capital managementOrchestra biomed holdingsGet free reportOrchestra biomedCapital managementCharles schwab investment managementSchwab investment management

Orchestra bioelectronics tune hypertension in pacemaker patients

Orchestra Biomed Holdings Inc. randomized the first patient in the BACKBEAT pivotal study investigating the use of its atrioventricular interval modulation (AVIM) therapy as a treatment for patients with uncontrolled hypertension implanted with a Medtronic plc pacemaker. AVIM therapy is an investigational patented bioelectronic therapy designed to immediately and durably reduce blood pressure.

Orchestra biomed holdings incOrchestra biomed holdingsAvim therapyMedtronic plc

Baystreet ca - Orchestra, Medtronic Join Forces

Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) watched its shares soar Tuesday, as the company, a biomedical concern accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the U.S. Food and Drug Administration .

David hochmanOrchestra biomed holdings incDrug administrationOrchestra biomed holdingsOrchestra biomed